                               SEQUENCE LISTING

<110> CYVAX, INC
 
<120> COMPOSITIONS AND METHODS FOR TREATING MELANOMA

<130> 19540_0104PTWO_SL

<140> 
<141> 

<150> 62/078,225
<151> 2014-11-11

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 1017
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
atggcacatc accaccacca tcactccgcg gctcttgaag tcctctttca gggacccggg       60

tacctcgaca tggcaagcaa ctacgactgt tgcctctcgt acatacagac gcctcttcct      120

tccagagcta ttgtgggttt cacaagacag atggccgatg aagcttgtga cattaatgct      180

atcatctttc acacgaagaa aagaaaatct gtgtgcgctg atccaaagca gaactgggtg      240

aaaagggctg tgaacctcct cagcctaaga gtcaagaaga tggaattcaa cgacgctcag      300

gcgccgaaga gtctcgaggc tagaaaagta cccagaaacc aggactggct tggtgtctca      360

aggcaactca gaaccaaagc ctggaacagg cagctgtatc cagagtggac agaagcccag      420

agacttgact gctggagagg tggtcaagtg tccctcaagg tcagtaatga tgggcctaca      480

ctgattggtg caaatgcctc cttctctatt gccttgaact tccctggaag ccaaaaggta      540

ttgccagatg ggcaggttat ctgggtcaac aataccatca tcaatgggag ccaggtgtgg      600

ggaggacagc cagtgtatcc ccaggaaact gacgatgcct gcatcttccc tgatggtgga      660

ccttgcccat ctggctcttg gtctcagaag agaagctttg tttatgtctg gaagacctgg      720

ggccaatact ggcaagttct agggggccca gtgtctgggc tgagcattgg gacaggcagg      780

gcaatgctgg gcacacacac catggaagtg actgtctacc atcgccgggg atcccggagc      840

tatgtgcctc ttgctcattc cagctcagcc ttcaccatta ctgaccaggt gcctttctcc      900

gtgagcgtgt cccagttgcg ggccttggat ggagggaaca agcacttcct gagaaatcta      960

gagagatccg cagaagaaca gaaactgatc tcagaagagg atctggcctg acctagg        1017


<210> 2
<211> 336
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Met Ala His His His His His His Ser Ala Ala Leu Glu Val Leu Phe 
1               5                   10                  15      


Gln Gly Pro Gly Tyr Leu Asp Met Ala Ser Asn Tyr Asp Cys Cys Leu 
            20                  25                  30          


Ser Tyr Ile Gln Thr Pro Leu Pro Ser Arg Ala Ile Val Gly Phe Thr 
        35                  40                  45              


Arg Gln Met Ala Asp Glu Ala Cys Asp Ile Asn Ala Ile Ile Phe His 
    50                  55                  60                  


Thr Lys Lys Arg Lys Ser Val Cys Ala Asp Pro Lys Gln Asn Trp Val 
65                  70                  75                  80  


Lys Arg Ala Val Asn Leu Leu Ser Leu Arg Val Lys Lys Met Glu Phe 
                85                  90                  95      


Asn Asp Ala Gln Ala Pro Lys Ser Leu Glu Ala Arg Lys Val Pro Arg 
            100                 105                 110         


Asn Gln Asp Trp Leu Gly Val Ser Arg Gln Leu Arg Thr Lys Ala Trp 
        115                 120                 125             


Asn Arg Gln Leu Tyr Pro Glu Trp Thr Glu Ala Gln Arg Leu Asp Cys 
    130                 135                 140                 


Trp Arg Gly Gly Gln Val Ser Leu Lys Val Ser Asn Asp Gly Pro Thr 
145                 150                 155                 160 


Leu Ile Gly Ala Asn Ala Ser Phe Ser Ile Ala Leu Asn Phe Pro Gly 
                165                 170                 175     


Ser Gln Lys Val Leu Pro Asp Gly Gln Val Ile Trp Val Asn Asn Thr 
            180                 185                 190         


Ile Ile Asn Gly Ser Gln Val Trp Gly Gly Gln Pro Val Tyr Pro Gln 
        195                 200                 205             


Glu Thr Asp Asp Ala Cys Ile Phe Pro Asp Gly Gly Pro Cys Pro Ser 
    210                 215                 220                 


Gly Ser Trp Ser Gln Lys Arg Ser Phe Val Tyr Val Trp Lys Thr Trp 
225                 230                 235                 240 


Gly Gln Tyr Trp Gln Val Leu Gly Gly Pro Val Ser Gly Leu Ser Ile 
                245                 250                 255     


Gly Thr Gly Arg Ala Met Leu Gly Thr His Thr Met Glu Val Thr Val 
            260                 265                 270         


Tyr His Arg Arg Gly Ser Arg Ser Tyr Val Pro Leu Ala His Ser Ser 
        275                 280                 285             


Ser Ala Phe Thr Ile Thr Asp Gln Val Pro Phe Ser Val Ser Val Ser 
    290                 295                 300                 


Gln Leu Arg Ala Leu Asp Gly Gly Asn Lys His Phe Leu Arg Asn Leu 
305                 310                 315                 320 


Glu Arg Ser Ala Glu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Ala 
                325                 330                 335     


<210> 3
<211> 1032
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 3
atgaacccaa gtgctgccgt cattttctgc ctcatcctgc tgggtctgag tgggactcaa       60

gggatcctcg acatggcaag caactacgac tgttgcctct cgtacataca gacgcctctt      120

ccttccagag ctattgtggg tttcacaaga cagatggccg atgaagcttg tgacattaat      180

gctatcatct ttcacacgaa gaaaagaaaa tctgtgtgcg ctgatccaaa gcagaactgg      240

gtgaaaaggg ctgtgaacct cctcagccta agagtcaaga agatggaatt caacgacgct      300

caggcgccga agagtctcga ggctagaaaa gtacccagaa accaggactg gcttggtgtc      360

tcaaggcaac tcagaaccaa agcctggaac aggcagctgt atccagagtg gacagaagcc      420

cagagacttg actgctggag aggtggtcaa gtgtccctca aggtcagtaa tgatgggcct      480

acactgattg gtgcaaatgc ctccttctct attgccttga acttccctgg aagccaaaag      540

gtattgccag atgggcaggt tatctgggtc aacaatacca tcatcaatgg gagccaggtg      600

tggggaggac agccagtgta tccccaggaa actgacgatg cctgcatctt ccctgatggt      660

ggaccttgcc catctggctc ttggtctcag aagagaagct ttgtttatgt ctggaagacc      720

tggggccaat actggcaagt tctagggggc ccagtgtctg ggctgagcat tgggacaggc      780

agggcaatgc tgggcacaca caccatggaa gtgactgtct accatcgccg gggatcccgg      840

agctatgtgc ctcttgctca ttccagctca gccttcacca ttactgacca ggtgcctttc      900

tccgtgagcg tgtcccagtt gcgggccttg gatggaggga acaagcactt cctgagaaat      960

ctagagagat ccgcagaaga acagaaactg atctcagaag aggatctggc ccaccaccat     1020

caccatcact aa                                                         1032


<210> 4
<211> 343
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Met Asn Pro Ser Ala Ala Val Ile Phe Cys Leu Ile Leu Leu Gly Leu 
1               5                   10                  15      


Ser Gly Thr Gln Gly Ile Leu Asp Met Ala Ser Asn Tyr Asp Cys Cys 
            20                  25                  30          


Leu Ser Tyr Ile Gln Thr Pro Leu Pro Ser Arg Ala Ile Val Gly Phe 
        35                  40                  45              


Thr Arg Gln Met Ala Asp Glu Ala Cys Asp Ile Asn Ala Ile Ile Phe 
    50                  55                  60                  


His Thr Lys Lys Arg Lys Ser Val Cys Ala Asp Pro Lys Gln Asn Trp 
65                  70                  75                  80  


Val Lys Arg Ala Val Asn Leu Leu Ser Leu Arg Val Lys Lys Met Glu 
                85                  90                  95      


Phe Asn Asp Ala Gln Ala Pro Lys Ser Leu Glu Ala Arg Lys Val Pro 
            100                 105                 110         


Arg Asn Gln Asp Trp Leu Gly Val Ser Arg Gln Leu Arg Thr Lys Ala 
        115                 120                 125             


Trp Asn Arg Gln Leu Tyr Pro Glu Trp Thr Glu Ala Gln Arg Leu Asp 
    130                 135                 140                 


Cys Trp Arg Gly Gly Gln Val Ser Leu Lys Val Ser Asn Asp Gly Pro 
145                 150                 155                 160 


Thr Leu Ile Gly Ala Asn Ala Ser Phe Ser Ile Ala Leu Asn Phe Pro 
                165                 170                 175     


Gly Ser Gln Lys Val Leu Pro Asp Gly Gln Val Ile Trp Val Asn Asn 
            180                 185                 190         


Thr Ile Ile Asn Gly Ser Gln Val Trp Gly Gly Gln Pro Val Tyr Pro 
        195                 200                 205             


Gln Glu Thr Asp Asp Ala Cys Ile Phe Pro Asp Gly Gly Pro Cys Pro 
    210                 215                 220                 


Ser Gly Ser Trp Ser Gln Lys Arg Ser Phe Val Tyr Val Trp Lys Thr 
225                 230                 235                 240 


Trp Gly Gln Tyr Trp Gln Val Leu Gly Gly Pro Val Ser Gly Leu Ser 
                245                 250                 255     


Ile Gly Thr Gly Arg Ala Met Leu Gly Thr His Thr Met Glu Val Thr 
            260                 265                 270         


Val Tyr His Arg Arg Gly Ser Arg Ser Tyr Val Pro Leu Ala His Ser 
        275                 280                 285             


Ser Ser Ala Phe Thr Ile Thr Asp Gln Val Pro Phe Ser Val Ser Val 
    290                 295                 300                 


Ser Gln Leu Arg Ala Leu Asp Gly Gly Asn Lys His Phe Leu Arg Asn 
305                 310                 315                 320 


Leu Glu Arg Ser Ala Glu Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
                325                 330                 335     


Ala His His His His His His 
            340             


<210> 5
<211> 213
<212> DNA
<213> Homo sapiens

<400> 5
gcagcaagca actttgactg ctgtcttgga tacacagacc gtattcttca tcctaaattt       60

attgtgggct tcacacggca gctggccaat gaaggctgtg acatcaatgc tatcatcttt      120

cacacaaaga aaaagttgtc tgtgtgcgca aatccaaaac agacttgggt gaaatatatt      180

gtgcgtctcc tcagtaaaaa agtcaagaac atg                                   213


<210> 6
<211> 71
<212> PRT
<213> Homo sapiens

<400> 6
Ala Ala Ser Asn Phe Asp Cys Cys Leu Gly Tyr Thr Asp Arg Ile Leu 
1               5                   10                  15      


His Pro Lys Phe Ile Val Gly Phe Thr Arg Gln Leu Ala Asn Glu Gly 
            20                  25                  30          


Cys Asp Ile Asn Ala Ile Ile Phe His Thr Lys Lys Lys Leu Ser Val 
        35                  40                  45              


Cys Ala Asn Pro Lys Gln Thr Trp Val Lys Tyr Ile Val Arg Leu Leu 
    50                  55                  60                  


Ser Lys Lys Val Lys Asn Met 
65                  70      


